Relationship between 3-month National Institutes of Health Stroke Scale score and dependence in ischemic stroke patients.
BACKGROUND
The National Institutes of Health Stroke Scale (NIHSS) provides a standardized measure of stroke severity and is frequently captured to assess 3-month outcome. Other outcome measures have been assessed for the relationship to dependence; a clinically relevant outcome. The relationship between NIHSS score and functional dependence is unknown. The purpose of this study was to assess the relationship between NIHSS score and accepted measures of dependence in surviving ischemic stroke patients.


METHODS
3-month NIHSS scores were compared to residence and Glasgow Outcome Scale (GOS) scores at 3 months in the Randomized Trial of Tirilazad Mesylate in Patients with Acute Stroke (RANTTAS). For residence, patients who were in a nursing home, chronic hospital or substantially dependent on a caregiver were characterized as 'dependent'. For GOS, a score of 3 (severely disabled) or 4 (vegetative) was characterized as 'dependent'. The sensitivity, specificity and positive (PPV) and negative predictive values (NPV) for various NIHSS score cut points compared to dependence were calculated. Logistic regression analysis was used to assess the association between the NIHSS score and dependence.


RESULTS
In 385 subjects from the RANTTAS, an NIHSS score cut point of > or =15 resulted in 100% of subjects identified as being dependent by residence, sensitivity = 24%, specificity = 100%, PPV = 100% and NPV = 80%. Using GOS as the measure of dependence, the results were almost identical. NIHSS was strongly related to dependence with an area under the receiver operating characteristic curve (AUC) = 0.86 for residence and an AUC = 0.94 for GOS.


CONCLUSIONS
3-month NIHSS score is strongly associated with dependence. An NIHSS score of > or =15 at 3 months may be a reasonable estimate of subjects who are highly likely to be dependent at 3 months. These data require validation in an independent data set.
Johnston
Karen C
KC
Department of Neurology, University of Virginia, Charlottesville, VA 22908-0394, USA. kj4v@virginia.edu
Wagner
Douglas P
DP
D000203:Activities of Daily Living; D000367:Age Factors; D000368:Aged; D002545:Brain Ischemia / Q000150:complications / Q000453:epidemiology; D004311:Double-Blind Method; D005006:Ethnicity; D005260:Female; D023261:Glasgow Outcome Scale; D006801:Humans; D016015:Logistic Models; D008297:Male; D018696:Neuroprotective Agents / Q000627:therapeutic use; D011281:Pregnatrienes / Q000627:therapeutic use; D012372:ROC Curve; D012737:Sex Factors; D020521:Stroke / Q000453:epidemiology* / Q000209:etiology / Q000503:physiopathology; D017741:Survivors; D016896:Treatment Outcome
D018696:Neuroprotective Agents; D011281:Pregnatrienes; C053355:tirilazad